As hospital and health system CEOs work to advance key strategies in 2026 — from ambulatory investments to artificial intelligence integration — ...

Thank you, Ingrid, and good morning. At NovoCure, our mission is to extend survival in some of the most aggressive forms of cancer. Launching tumor treating field's therapy in non-small cell lung ...

The Medicare Innovation Center has proposed two drug pricing models that would lower the cost of certain drugs to reflect international prices, which are often significantly lower than wh | CMS' ...

BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has completed a third preliminary ...

Fitch cited concerns that Humana’s EBITDA-based margins are unlikely to recover to levels supporting previous ratings. The downgrade reflects elevated healthcare utilization across the sector and ...

Mid-Atlantic Permanente Medical Group shows how trusted data and technology can turn value-based care into better outcomes, ...

Seeing a private specialist increasingly comes with massive gap payments. On average, out-of-pocket fees to see a specialist amount to about $300 a ...

Self-insured employers face legal challenges in adopting value-based models, including ERISA fiduciary duties, HIPAA restrictions, and antitrust concerns. Standardized data definitions and performance ...

Introducing our inaugural Forbes Top Hospitals list. Developed with measurement experts, clinicians, health policy researchers and patient advocates, the ratings showcase hospitals offering ...

Zing Health Inc. is taking a second swing at forcing the Department of Health and Human Services to help rectify the economic damage it says it suffered as a result of an improper termination from the ...